Cogent Biosciences is Biotechnology in United States that focus on Cogent Biosciences Inc business. Founded in 2014. They cover business area such as Cogent Biosciences Inc, precision therapy, genetically define disease, patient, KIT exon, case, Systemic Mastocytosis (SM, unchecked proliferation, mast cell, advanced gastrointestinal stromal tumor, GIST, a type, cancer, strong dependence, oncogenic KIT.
2014
( 10 years old in 2024 )
Cogent Biosciences Inc
-
200 Cambridge Park Drive
Suite 2500
Cambridge, MA 02140
United States
Private
Cogent Biosciences Incprecision therapygenetically define diseasepatientKIT exoncaseSystemic Mastocytosis (SMunchecked proliferationmast celladvanced gastrointestinal stromal tumorGISTa typecancerstrong dependenceoncogenic KIT
* We use standard office opening hours in near Cogent Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cogent Biosciences is Biotechnology business from United States that founded in 2014 (10 years old in 2024), Cogent Biosciences business is focusing on Cogent Biosciences Inc.
Cogent Biosciences headquarter office and corporate office address is located in 200 Cambridge Park Drive Suite 2500 Cambridge, MA 02140 United States.
Cogent Biosciences was founded in United States.
In 2024, Cogent Biosciences is currently focus on Cogent Biosciences Inc sector.
Above is snippet of Google Trends for "Cogent Biosciences Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cogent Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
